Advances in Vaccine Development and the Immune Response Against Toxoplasmosis in Sheep and Goats

Overview

Journal Front Vet Sci

Specialty Veterinary Medicine

Date 2022 Sep 12

PMID 36090161

Authors

Tanjila Hasan

Yoshifumi Nishikawa

Affiliations

Soon will be listed here.

Abstract

Toxoplasmosis is a zoonotic, parasitic infection caused by the intracellular, apicomplexan parasite , which infects all homeothermic animals including humans. The parasite has a major economic impact on the livestock industry. This is especially true for small ruminants (sheep, goats) as it is one of the most likely reasons for reproductive disorders in these animals. Primary infection in sheep and goats can result in a fetus that is mummified or macerated, fetal embryonic death, abortion, stillbirth, or the postnatal death of neonates, all of which threaten sheep and goat rearing globally. Humans can also become infected by ingesting bradyzoite-containing chevon or mutton, or the contaminated milk of sheep or goats, highlighting the zoonotic significance of this parasite. This article reviews the advances in vaccine development over recent decades and our current understanding of the immune response to toxoplasmosis in small ruminants (sheep, and goats).

Citing Articles

Occurrence of in cattle and sheep in Akmola and Kostanay regions of Kazakhstan.

Tursunov K, Tokhtarova L, Adish Z, Mustafina R Vet World. 2025; 17(12):2944-2949.

PMID: 39897362 PMC: 11784043. DOI: 10.14202/vetworld.2024.2944-2949.

Nanospheres as the delivery vehicle: novel application of ribosomal protein S2 in PLGA and chitosan nanospheres against acute toxoplasmosis.

Qi W, Yu Y, Yang C, Wang X, Jiang Y, Zhang L Front Immunol. 2024; 15:1475280.

PMID: 39416787 PMC: 11480959. DOI: 10.3389/fimmu.2024.1475280.

infection: novel emerging therapeutic targets.

Muller J, Hemphill A Expert Opin Ther Targets. 2023; 27(4-5):293-304.

PMID: 37212443 PMC: 10330558. DOI: 10.1080/14728222.2023.2217353.

Nanoparticles as a Delivery System of Antigens for the Development of an Effective Vaccine against .

Brito C, Lourenco C, Magalhaes J, Reis S, Borges M Vaccines (Basel). 2023; 11(4).

PMID: 37112645 PMC: 10142924. DOI: 10.3390/vaccines11040733.

and Co-Infections with Other Major Pathogens Causing Abortion in Small Ruminant Flocks in the Iberian Peninsula.

Ramo M, Benito A, Quilez J, Monteagudo L, Baselga C, Tejedor M Animals (Basel). 2022; 12(24).

PMID: 36552374 PMC: 9774532. DOI: 10.3390/ani12243454.

References

Innes E, Panton W, Sanderson A, Thomson K, Wastling J, Maley S . Induction of CD4+ and CD8+ T cell responses in efferent lymph responding to Toxoplasma gondii infection: analysis of phenotype and function. Parasite Immunol. 1995; 17(3):151-60. DOI: 10.1111/j.1365-3024.1995.tb01017.x. View

Stover C, de la Cruz V, Fuerst T, Burlein J, Benson L, Bennett L . New use of BCG for recombinant vaccines. Nature. 1991; 351(6326):456-60. DOI: 10.1038/351456a0. View

Buxton D, Innes E . A commercial vaccine for ovine toxoplasmosis. Parasitology. 1995; 110 Suppl:S11-6. DOI: 10.1017/s003118200000144x. View

Hiszczynska-Sawicka E, Li H, Xu J, Oledzka G, Kur J, Bickerstaffe R . Comparison of immune response in sheep immunized with DNA vaccine encoding Toxoplasma gondii GRA7 antigen in different adjuvant formulations. Exp Parasitol. 2009; 124(4):365-72. DOI: 10.1016/j.exppara.2009.11.015. View

Chaouat G, Ledee-Bataille N, Dubanchet S, Zourbas S, Sandra O, Martal J . Reproductive immunology 2003: reassessing the Th1/Th2 paradigm?. Immunol Lett. 2004; 92(3):207-14. DOI: 10.1016/j.imlet.2004.01.011. View

Robert-Gangneux F, Darde M . Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev. 2012; 25(2):264-96. PMC: 3346298. DOI: 10.1128/CMR.05013-11. View

Entrican G . Immune regulation during pregnancy and host-pathogen interactions in infectious abortion. J Comp Pathol. 2002; 126(2-3):79-94. DOI: 10.1053/jcpa.2001.0539. View

Wilkins M, OConnell E, Te Punga W . Toxoplasmosis in sheep III. Further evaluation of the ability of a live Toxoplasma gondii vaccine to prevent lamb losses and reduce congenital infection following experimental oral challenge. N Z Vet J. 1988; 36(2):86-9. DOI: 10.1080/00480169.1988.35489. View

Dubey J, Cerqueira-Cezar C, Murata F, Kwok O, Yang Y, Su C . All about toxoplasmosis in cats: the last decade. Vet Parasitol. 2020; 283:109145. DOI: 10.1016/j.vetpar.2020.109145. View

10.

Hiszczynska-Sawicka E, Li H, Xu J, Holec-Gasior L, Kur J, Sedcole R . Modulation of immune response to Toxoplasma gondii in sheep by immunization with a DNA vaccine encoding ROP1 antigen as a fusion protein with ovine CD154. Vet Parasitol. 2011; 183(1-2):72-8. DOI: 10.1016/j.vetpar.2011.06.010. View

11.

Kutzler M, Weiner D . DNA vaccines: ready for prime time?. Nat Rev Genet. 2008; 9(10):776-88. PMC: 4317294. DOI: 10.1038/nrg2432. View

12.

Ferguson D, HUTCHISON W, Dunachie J, SIIM J . Ultrastructural study of early stages of asexual multiplication and microgametogony of Toxoplasma gondii in the small intestine of the cat. Acta Pathol Microbiol Scand B Microbiol Immunol. 1974; 82(2):167-81. DOI: 10.1111/j.1699-0463.1974.tb02309.x. View

13.

Ferguson D . Identification of faecal transmission of Toxoplasma gondii: Small science, large characters. Int J Parasitol. 2009; 39(8):871-5. DOI: 10.1016/j.ijpara.2009.01.003. View

14.

Hiszczynska-Sawicka E, Oledzka G, Holec-Gasior L, Li H, Xu J, Sedcole R . Evaluation of immune responses in sheep induced by DNA immunization with genes encoding GRA1, GRA4, GRA6 and GRA7 antigens of Toxoplasma gondii. Vet Parasitol. 2011; 177(3-4):281-9. DOI: 10.1016/j.vetpar.2010.11.047. View

15.

Li B, Oledzka G, McFARLANE R, Spellerberg M, Smith S, Gelder F . Immunological response of sheep to injections of plasmids encoding Toxoplasma gondii SAG1 and ROP1 genes. Parasite Immunol. 2010; 32(9-10):671-83. DOI: 10.1111/j.1365-3024.2010.01228.x. View

16.

Lunden A . Immune responses in sheep after immunization with Toxoplasma gondii antigens incorporated into iscoms. Vet Parasitol. 1995; 56(1-3):23-35. DOI: 10.1016/0304-4017(94)00670-8. View

17.

Stelzer S, Basso W, Benavides Silvan J, Ortega-Mora L, Maksimov P, Gethmann J . infection and toxoplasmosis in farm animals: Risk factors and economic impact. Food Waterborne Parasitol. 2020; 15:e00037. PMC: 7033994. DOI: 10.1016/j.fawpar.2019.e00037. View

18.

Dubey J . Infectivity and pathogenicity of Toxoplasma gondii oocysts for cats. J Parasitol. 1996; 82(6):957-61. View

19.

Castano P, Fuertes M, Ferre I, Fernandez M, Ferreras M, Moreno-Gonzalo J . Placental thrombosis in acute phase abortions during experimental Toxoplasma gondii infection in sheep. Vet Res. 2014; 45:9. PMC: 3931317. DOI: 10.1186/1297-9716-45-9. View

20.

Francis M . Recent Advances in Vaccine Technologies. Vet Clin North Am Small Anim Pract. 2017; 48(2):231-241. PMC: 7132473. DOI: 10.1016/j.cvsm.2017.10.002. View